Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amyris, Inc. - Common Stock (NQ:AMRS)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 18, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amyris, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Short Interest Sector Focus: Basic Materials Sector
As of the close of business on Thursday, 8/4, we captured the Top 10 Highest Short Interest % stocks within the Basic Materials Sector. The average short interest for stocks within the Basic Materials... 
Via Benzinga
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
Gainers 
Via Benzinga
Earnings Scheduled For March 1, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
Short Interest Sector Focus: Basic Materials Sector
As of the close of business on Tuesday, 7/19, we captured the Top 10 Highest Short Interest % stocks within the Basic Materials Sector. The average short interest for stocks within the Basic Materials... 
Via Benzinga
Nasdaq Rises More Than 300 Points; Crude Oil Moves Higher
U.S. stocks extended gains toward the end of trading, with the Nasdaq Composite gaining around 3% on Tuesday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022
Upgrades 
Via Benzinga
Global Plant Based Protein Market Expected To Reach $40 Billion by 2027
Palm Beach, FL – June 14, 2022 – FinancialNewsMedia.com News Commentary – The pandemic has considerably transformed consumer buying patterns, with a steady shift being witnessed toward health-improving... 
Via FinancialNewsMedia
20 Stocks Moving in Thursday's Pre-Market Session
Gainers TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares rose 51.2% to $0.9603 in pre-market trading after dipping 18% on Wednesday. 
Via Benzinga
70 Biggest Movers From Friday
Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022
Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of... 
Via Benzinga
88 Biggest Movers From Yesterday
Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit. 
Via Benzinga
61 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Mid-Afternoon Market Update: Crude Oil Down Over 1%; Jumia Technologies Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 200 points on Tuesday. 
Via Benzinga
76 Biggest Movers From Yesterday
Gainers Bright Green Corp. (NASDAQ: BGXX) jumped 90.5% to close at $48.08 on Wednesday. Bright Green Corporation, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to... 
Via Benzinga
34 Stocks Moving in Wednesday's Pre-Market Session
Gainers Embark Technology, Inc. (NASDAQ: EMBK) rose 36.4% to $1.95 in pre-market trading. Embark Technology posted a Q1 loss of $0.04 per share. 
Via Benzinga
110 Biggest Movers From Friday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital. 
Via Benzinga
103 Biggest Movers From Yesterday
Gainers 
Via Benzinga
90 Biggest Movers From Yesterday
Gainers 
Via Benzinga
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine... 
Via Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first... 
Via Benzinga
3 New ETFs to Put on Your January Buy List
2022 is expected to be a record-setting year for funds, with more new ETFs with different themes becoming available. 
Via InvestorPlace
Amyris, ImmunityBio Shares Trading Higher On COVID-19 Vaccine Joint Venture
Amyris Inc (NASDAQ: AMRS) and ImmunityBio (NASDAQ: IBRX) have completed their previously announced joint venture agreement to accelerate the... 
Via Benzinga
The 7 Best Green Energy Stocks to Grow Your Portfolio in 2022
Pressure to become more environmentally responsible is a clear mandate for companies, making these seven green energy stocks ideal for 2022 portfolios. 
Via InvestorPlace
3 Growth Stocks to Fuel Your 2022 Financial Freedom
This basket of industrial and electric vehicle stocks is primed to pole vault your portfolio. 
Via The Motley Fool
Topics Electric Vehicles
Exposures Electric Vehicles
Federman & Sherwood Announces Certification of Securities Class Action Lawsuit Against Amyris, Inc.
From Federman & Sherwood
Via Business Wire
Jim Cramer Prefers Union Pacific Over CSX
On CNBC’s "Mad Money Lightning Round," Jim Cramer said although CSX Corporation (NASDAQ: 
Via Benzinga
Why Shares of Amyris Are Plummeting This Week
There's nothing artificial about the plunging price of this synthetic biology stock. 
Via The Motley Fool
75 Biggest Movers From Yesterday
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Check out these big penny stock gainers and losers... 
Via Benzinga
Why Shares of Amyris Are Getting Crushed Today
Bears are turning their backs on this synbio stock today. 
Via The Motley Fool
Mid-Afternoon Market Update: Crude Oil Rises Over 2%; Tactile Systems Technology Shares Plummet
Toward the end of trading Tuesday, the Dow traded down 0.66% to 36,192.03 while the NASDAQ fell 0.90% to 15,838.46. The S&P also fell, dropping 0.65% to 4,671.36. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback